FinVector Oy
Anna-Maria Tuokko is a seasoned finance professional with extensive experience in senior management and board roles across various companies. Currently serving as Senior Manager at FinVector Oy since September 2023 and as a Board Member at Lignell & Piispanen since June 2021, Anna-Maria has previously held significant positions including Chief Financial Officer at Galena Pharma Oy and Vetrea. Expertise encompasses finance analysis, reporting, business planning, strategy, cash flow management, HR, and team leadership. Educational qualifications include a Master's degree in Accounting and Finance from the University of Eastern Finland, earned between 2005 and 2008.
This person is not in the org chart
This person is not in any teams
FinVector Oy
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for theproduction of gene therapy products for clinical and commercial supply.